Beijing Wantai Biological Pharmacy Enterprise Co Ltd Cash Flow-to-Debt Ratio
Beijing Wantai Biological Pharmacy Enterprise Co Ltd cash flow-to-debt ratio. Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of CN¥127.35 Million could theoretically repay 0% of its total liabilities (CN¥2.10 Billion) in one year. Check Beijing Wantai Biological Pharmacy Enter total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2013–2025)
Cash flow-to-debt ratio of Beijing Wantai Biological Pharmacy Enterprise Co Ltd from 2013 to 2025. Historical debt coverage capacity for Beijing Wantai Biological Pharmacy Enterprise Co Ltd across 13 annual periods. Check 603392 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Cash Flow-to-Debt Ratio by Year (2013–2025)
Beijing Wantai Biological Pharmacy Enterprise Co Ltd cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Beijing Wantai Biological Pharmacy Enterprise Co Ltd. For the full cash flow conversion analysis, see Beijing Wantai Biological Pharmacy Enter (603392) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | CN¥89.75 Million | CN¥2.01 Billion | ▼ -71.8% |
| 2024 | 0.16x | CN¥355.08 Million | CN¥2.24 Billion | ▼ -72.0% |
| 2023 | 0.57x | CN¥1.60 Billion | CN¥2.83 Billion | ▼ -49.8% |
| 2022 | 1.13x | CN¥4.13 Billion | CN¥3.66 Billion | ▲ +66.5% |
| 2021 | 0.68x | CN¥1.68 Billion | CN¥2.48 Billion | ▲ +33.6% |
| 2020 | 0.51x | CN¥468.21 Million | CN¥923.29 Million | ▲ +8.6% |
| 2019 | 0.47x | CN¥272.68 Million | CN¥584.19 Million | ▼ -0.5% |
| 2018 | 0.47x | CN¥208.31 Million | CN¥444.24 Million | ▲ +141.5% |
| 2017 | 0.19x | CN¥146.97 Million | CN¥756.80 Million | ▼ -25.7% |
| 2016 | 0.26x | CN¥129.40 Million | CN¥494.76 Million | ▼ -34.7% |
| 2015 | 0.40x | CN¥151.84 Million | CN¥378.93 Million | ▼ -31.9% |
| 2014 | 0.59x | CN¥132.43 Million | CN¥225.19 Million | ▲ +35.2% |
| 2013 | 0.43x | CN¥97.83 Million | CN¥224.92 Million | — |